Skip to main content

Finance

By Anthony Vecchione | 12:10 pm | August 22, 2025
Inbox Health's patient billing team will be responsible for overseeing inbound calls, chat and email for CHE Behavioral Health Services' patient queries.
By Anthony Vecchione | 12:03 pm | August 22, 2025
The company will use the funds to hasten product development, expand its clinical intelligence capabilities and foster growth of its customer service implementation team.
By Anthony Vecchione | 04:34 pm | August 20, 2025
The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.
By Jessica Hagen | 07:07 pm | August 18, 2025
The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.
By Anthony Vecchione | 12:51 pm | August 15, 2025
The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.
By HIMSS TV | 09:00 am | August 12, 2025
Today, 60% of all healthcare payments are in some form of value-based care if you include fee for service with quality metrics for upside bonuses, says Dave Snow, CEO of Cedar Gate Technologies.
By Anthony Vecchione | 05:16 pm | August 11, 2025
The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.
By Jessica Hagen | 10:47 am | August 08, 2025
The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.
By HIMSS TV | 09:00 am | August 07, 2025
Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.
By Jessica Hagen | 11:32 am | August 06, 2025
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.